Quick Answer (for busy buyers)
Applicable requirements and regulatory responsibilities depend on product classification and target market. Confirm the responsible parties and any filing or update obligations for your specific project.
- For a US launch, review the exact intended use before formula and artwork approval. FDA distinguishes cosmetics from drugs by intended use, including claims made on labels and in marketing.
- Claims to treat or prevent disease or affect the body’s structure or function can establish drug status. Do not treat claims such as relieving dry-eye symptoms or treating an eye infection as ordinary cosmetic claims.
- Appearance-focused claims for a cream or serum used on skin around the eyes are different from therapeutic claims. A product intended to be instilled into the eye requires a separate regulatory assessment; a cosmetic label alone does not establish its classification.
- Have a qualified US regulatory professional assess the formula, route of application and full claim list. Do not assume that every drug claim qualifies for an OTC pathway or that cosmetic testing is sufficient.
- Confirm product feasibility, required testing, documentation, packaging and project-specific MOQ and timelines before placing an order. This answer does not imply that LAEYO offers sterile ophthalmic or drug manufacturing.
Buyer outcome
Use the answer to clarify requirements, compare options, and prepare project questions.
Before requesting a quote
Confirm the target market, product type, packaging requirements, and unresolved details.
⚠️
This page is a practical buyer guide. For regulatory topics, verify current requirements with the relevant authorities and qualified advisers for your product and target market.
